• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    NYSE Content Update: Alysa Liu Rings NYSE Bell After Winning Two Gold Medals

    3/4/26 8:55:00 AM ET
    $ICE
    $PFE
    $SMWB
    Investment Bankers/Brokers/Service
    Finance
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $ICE alert in real time by email

    NYSE issues a pre-market daily advisory direct from the trading floor.

    NEW YORK, March 4, 2026 /CNW/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins. 

    Ashley Mastronardi delivers the pre-market update on March 4th

    • Equities are volatile amid the ongoing conflict in the Middle East, with President Trump saying late Tuesday that the U.S. will provide risk insurance to all maritime trade in the Persian Gulf.
    • Two-time Olympic gold-medalist figure skater Alysa Liu joined Kristen Scholer for an interview from the Rink at Rockefeller Center yesterday that will air on NYSE Live this morning.
    • Ronald McDonald House New York, The New York Rangers, and RBC Capital Markets will ring the Opening Bell to celebrate this week's 32nd Annual Skate with the Greats.
    • Baruch Toledano of Similarweb (NYSE:SMWB), a digital intelligence platform, will join NYSE Live to break down the results of its most recent Generative AI Brand Visibility Index Report.

    Opening Bell

    Ronald McDonald House NY, in partnership with RBC Capital Markets and the New York Rangers, celebrates the 32nd Annual Skate with the Greats.

    Closing Bell

    Pfizer (NYSE:PFE) rings the NYSE Closing Bell

    For market insights, IPO activity, and today's opening bell, download the NYSE TV App: TV.NYSE.com

    Rep. Dan Meuser (R-Pa.) at the NYSE on March 3

    NYSE Logo (PRNewsfoto/New York Stock Exchange)

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/nyse-content-update-alysa-liu-rings-nyse-bell-after-winning-two-gold-medals-302703947.html

    SOURCE New York Stock Exchange

    Cision View original content to download multimedia: http://www.newswire.ca/en/releases/archive/March2026/04/c1226.html

    Get the next $ICE alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ICE
    $PFE
    $SMWB

    CompanyDatePrice TargetRatingAnalyst
    Pfizer Inc.
    $PFE
    7/6/2026$28.00Buy → Hold
    HSBC Securities
    Pfizer Inc.
    $PFE
    6/10/2026$25.00Underperform → Sector Perform
    RBC Capital Mkts
    Similarweb Ltd.
    $SMWB
    4/10/2026$3.00Buy → Neutral
    Citigroup
    Intercontinental Exchange Inc.
    $ICE
    4/8/2026$190.00Outperform
    Keefe Bruyette
    Intercontinental Exchange Inc.
    $ICE
    3/6/2026$188.00Hold → Buy
    Deutsche Bank
    Pfizer Inc.
    $PFE
    3/2/2026$35.00Hold → Buy
    Argus
    Pfizer Inc.
    $PFE
    2/25/2026$25.00Underperform
    RBC Capital Mkts
    Pfizer Inc.
    $PFE
    2/20/2026$25.00Underweight
    Barclays
    More analyst ratings

    $ICE
    $PFE
    $SMWB
    SEC Filings

    View All

    Pfizer Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - PFIZER INC (0000078003) (Filer)

    6/18/26 1:17:22 PM ET
    $PFE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Pfizer Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

    8-K - PFIZER INC (0000078003) (Filer)

    6/18/26 7:07:07 AM ET
    $PFE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 11-K filed by Pfizer Inc.

    11-K - PFIZER INC (0000078003) (Filer)

    6/16/26 4:02:01 PM ET
    $PFE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ICE
    $PFE
    $SMWB
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for HYMPAVZI issued to PFIZER INC

    Submission status for PFIZER INC's drug HYMPAVZI (SUPPL-3) with active ingredient MARSTACIMAB-HNCQ has changed to 'Approval' on 06/05/2026. Application Category: BLA, Application Number: 761369, Application Classification:

    6/9/26 4:46:31 AM ET
    $PFE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    October 25, 2024 - FDA Roundup: October 25, 2024

    For Immediate Release: October 25, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA updated the advisory for the outbreak of E. coli O157:H7. A specific ingredient has not yet been confirmed as the source of the outbreak, but most sick people report eating McDonald’s Quarter Pounder burgers. Investigators are working to deter

    10/25/24 2:48:21 PM ET
    $PFE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for HYMPAVZI issued to PFIZER INC

    Submission status for PFIZER INC's drug HYMPAVZI (ORIG-1) with active ingredient MARSTACIMAB-HNCQ has changed to 'Approval' on 10/11/2024. Application Category: BLA, Application Number: 761369, Application Classification:

    10/15/24 2:57:27 PM ET
    $PFE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ICE
    $PFE
    $SMWB
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    FDA Grants Priority Review for Pfizer’s TALZENNA Plus XTANDI for the Treatment of Metastatic Prostate Cancer

    Supplemental application aims to expand use to men with HRR gene-mutated metastatic castration-sensitive prostate cancer Filing supported by Phase 3 TALAPRO-3 data demonstrating greater than 50% improvement in radiographic progression-free survival, with consistent benefit across BRCA and non-BRCA HRR gene alterations Pfizer Inc. (NYSE:PFE) today announced that the U.S. Food and Drug Administration (FDA) accepted for Priority Review a supplemental New Drug Application (sNDA) for TALZENNA® (talazoparib), an oral poly ADP-ribose polymerase (PARP) inhibitor, in combination with XTANDI® (enzalutamide), an androgen receptor pathway inhibitor (ARPI), in men with homologous recombination re

    7/22/26 4:30:00 PM ET
    $PFE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    NYSE Content Update: CNBC + NYSE Celebrate Extension of 30-Year Partnership

    NYSE issues a pre-market daily advisory direct from the trading floor.NEW YORK, July 22, 2026 /CNW/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins.  Ashley Mastronardi delivers the pre-market update on July 22ndInvestors react to sentiment surrounding the Middle East and await big tech earnings this afternoon.CNBC President KC Sullivan will join NYSE Live to discuss the strength and significance of CNBC's longstanding partnership with the NYSE.SERHANT.'s Executive Director of Commercial Bernadette Brennan will join NYSE Liv

    7/22/26 8:55:00 AM ET
    $ICE
    $PD
    Investment Bankers/Brokers/Service
    Finance
    Computer Software: Prepackaged Software
    Technology

    MultiLynq Becomes First Provider to Offer Connectivity to ICE Bonds' RMA Protocol

    Expands Dealer Access Across the ICE Bonds Marketplace Intercontinental Exchange, Inc. (NYSE:ICE), one of the world’s leading providers of financial market technology and data powering global capital markets, today announced that MultiLynq LLC, a financial technology solutions supplier for electronic fixed income trading, has become the first provider to offer connectivity to their customers to the ICE Bonds Risk Matching Auction (RMA) protocol. The RMA protocol, which is part of the ICE Bonds’ suite of trading solutions, conducts multiple dealer-to-dealer sweep auctions weekly for corporate bonds. The integration of the ICE Bonds RMA protocol through the ICE Application Programming Int

    7/22/26 8:30:00 AM ET
    $ICE
    Investment Bankers/Brokers/Service
    Finance

    $ICE
    $PFE
    $SMWB
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Executive Officer Offer Or bought $207,500 worth of Ordinary Shares (50,000 units at $4.15), increasing direct ownership by 1% to 4,744,396 units (SEC Form 4)

    4 - SIMILARWEB LTD. (0001842731) (Issuer)

    6/2/26 7:46:28 AM ET
    $SMWB
    Computer Software: Programming Data Processing
    Technology

    Director Eilam Barak bought $193,000 worth of Ordinary Shares (50,000 units at $3.86), increasing direct ownership by 97% to 101,315 units (SEC Form 4)

    4 - SIMILARWEB LTD. (0001842731) (Issuer)

    5/22/26 6:13:16 AM ET
    $SMWB
    Computer Software: Programming Data Processing
    Technology

    Director Beit-On Harel Moshe bought $291,750 worth of Ordinary Shares (75,000 units at $3.89), increasing direct ownership by 0.69% to 10,885,778 units (SEC Form 4)

    4 - SIMILARWEB LTD. (0001842731) (Issuer)

    5/21/26 6:17:44 AM ET
    $SMWB
    Computer Software: Programming Data Processing
    Technology

    $ICE
    $PFE
    $SMWB
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Pfizer downgraded by HSBC Securities with a new price target

    HSBC Securities downgraded Pfizer from Buy to Hold and set a new price target of $28.00

    7/6/26 8:56:06 AM ET
    $PFE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Pfizer upgraded by RBC Capital Mkts with a new price target

    RBC Capital Mkts upgraded Pfizer from Underperform to Sector Perform and set a new price target of $25.00

    6/10/26 8:16:22 AM ET
    $PFE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Similarweb downgraded by Citigroup with a new price target

    Citigroup downgraded Similarweb from Buy to Neutral and set a new price target of $3.00

    4/10/26 8:30:35 AM ET
    $SMWB
    Computer Software: Programming Data Processing
    Technology

    $ICE
    $PFE
    $SMWB
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    President, NYSE Group Martin Lynn C exercised 15,882 shares at a strike of $57.31 and sold $2,241,713 worth of shares (15,882 units at $141.15) as part of a pre-agreed trading plan (SEC Form 4)

    4 - Intercontinental Exchange, Inc. (0001571949) (Issuer)

    7/20/26 4:30:02 PM ET
    $ICE
    Investment Bankers/Brokers/Service
    Finance

    SEC Form 4 filed by Chairman & CEO Bourla Albert

    4 - PFIZER INC (0000078003) (Issuer)

    7/16/26 6:17:14 PM ET
    $PFE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 4 filed by Chairman & CEO Bourla Albert

    4 - PFIZER INC (0000078003) (Issuer)

    7/13/26 3:43:12 PM ET
    $PFE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ICE
    $PFE
    $SMWB
    Financials

    Live finance-specific insights

    View All

    NYSE Content Update: Easterly Launches Easterly Snow All Cap Value Fund

    NYSE issues a pre-market daily advisory direct from the trading floor.NEW YORK, June 29, 2026 /CNW/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins.  Pete Asch delivers the pre-market update on June 29thInvestors track new developments in the Middle East after the U.S. and Iran agreed to halt hostilities over the weekend.The city of Orlando, Florida says it's seeing more companies establish headquarters or expand business operations in the city.Mayor Buddy Dyer joins NYSE Live to discuss factors behind Orlando's transition

    6/29/26 8:55:00 AM ET
    $ICE
    $DB
    Investment Bankers/Brokers/Service
    Finance
    Major Banks

    Pfizer Declares Third-Quarter 2026 Dividend

    Board of Directors approves quarterly cash dividend of $0.43 per share Pfizer Inc. (NYSE:PFE) today announced that its board of directors declared a $0.43 third-quarter 2026 dividend on the company’s common stock, payable September 1, 2026, to holders of the Common Stock of record at the close of business on July 24, 2026. Pfizer is committed to maintaining, and over the longer term, growing the dividend, as part of its capital allocation strategy. The third-quarter 2026 cash dividend will be the 351st consecutive quarterly dividend paid by Pfizer. About Pfizer: Breakthroughs That Change Patients’ Lives At Pfizer, we apply science and our global resources to bring therapies to people

    6/24/26 3:52:00 PM ET
    $PFE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Pfizer Invites Public to View and Listen to Webcast of August 4 Conference Call with Analysts

    Pfizer Inc. (NYSE:PFE) invites investors and the general public to view and listen to a webcast of a conference call with investment analysts at 10:00 a.m. EDT on Tuesday, August 4, 2026. The purpose of the call is to provide an update on Pfizer’s results, as reflected in the company’s Second Quarter 2026 Performance Report, to be issued that morning. To view and listen to the webcast and view the Performance Report, visit our web site at www.pfizer.com/investors. Information on accessing and registering for the webcast will be available at www.pfizer.com/investors beginning today. Participants are advised to register in advance of the conference call. You can also listen to the confere

    6/23/26 10:00:00 AM ET
    $PFE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ICE
    $PFE
    $SMWB
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Similarweb Ltd.

    SC 13G/A - SIMILARWEB LTD. (0001842731) (Subject)

    11/26/24 4:50:46 PM ET
    $SMWB
    Computer Software: Programming Data Processing
    Technology

    SEC Form SC 13G/A filed by Similarweb Ltd. (Amendment)

    SC 13G/A - SIMILARWEB LTD. (0001842731) (Subject)

    2/20/24 9:42:20 AM ET
    $SMWB
    Computer Software: Programming Data Processing
    Technology

    SEC Form SC 13G/A filed by Similarweb Ltd. (Amendment)

    SC 13G/A - SIMILARWEB LTD. (0001842731) (Subject)

    2/14/24 9:13:32 AM ET
    $SMWB
    Computer Software: Programming Data Processing
    Technology

    $ICE
    $PFE
    $SMWB
    Leadership Updates

    Live Leadership Updates

    View All

    NIRI Chicago Elects 2026-2027 Officers and Directors

    The Chicago chapter of NIRI, The Association for Investor Relations (NIRI Chicago), has elected 10 officers and directors to its board for the 2026-2027 term, effective July 1. "As capital markets evolve, shareholder expectations continue to rise, and technological advancements reshape how companies engage with investors, the role of the investor relations officer continues to expand in scope and strategic importance," said Brooks O. Rennie, incoming chapter president. "NIRI Chicago is fortunate to be guided by an exceptional board of directors whose leadership, experience and commitment position our organization to remain a leading resource for investor relations professionals across the

    7/7/26 10:42:00 AM ET
    $BY
    $CF
    $TAP
    Major Banks
    Finance
    Agricultural Chemicals
    Industrials

    Similarweb Initiates CEO Succession Planning Process

    Similarweb Ltd. (NYSE:SMWB), a leading digital market intelligence company, today announced that its Board of Directors has initiated a formal search process for the company's next Chief Executive Officer, as part of a planned and orderly leadership transition. Founder and Chief Executive Officer Or Offer, who founded Similarweb in 2007, will mark 20 years leading the company in May 2027. Approaching that milestone, Mr. Offer has informed the Board of his intention to transition out of the CEO role and is working closely with the Board to ensure a thoughtful and seamless handover. Mr. Offer will continue to serve as CEO through the conclusion of the search and a transition period with his

    5/13/26 7:00:00 AM ET
    $SMWB
    Computer Software: Programming Data Processing
    Technology

    Similarweb Appoints Harel Beit-On as Chairman of its Board of Directors

    Similarweb Ltd. (NYSE:SMWB), a leading digital market intelligence company, today announced the appointment of Harel Beit-On as Chairman of its Board of Directors. Mr. Beit-On has served as a member of Similarweb's Board since 2017 and brings more than 30 years of experience in leadership positions and investment in technology companies. A co-founder and General Partner of the Viola Group, Mr. Beit-On has a strong investment track record as well as a long standing familiarity with Similarweb. Or Offer, Founder and CEO of Similarweb, said, "Harel has been a trusted advisor, mentor, and partner to me and to Similarweb over many years. As AI transforms how decisions are made across every ind

    3/26/26 8:00:00 AM ET
    $SMWB
    Computer Software: Programming Data Processing
    Technology